- Patent Title: Cyclic citrullinated peptide, rheumatoid arthritis diagnosis composition including the same, rheumatoid arthritis diagnosis method using the peptide or the composition, and method of screening diagnostic marker for rheumatoid arthritis
-
Application No.: US14849755Application Date: 2015-09-10
-
Publication No.: US10266568B2Publication Date: 2019-04-23
- Inventor: Min Park , Min-Jung Kang , Byung Hwa Jung , Young Sook Yoo
- Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Seoul
- Assignee: Korea Institute of Science and Technology
- Current Assignee: Korea Institute of Science and Technology
- Current Assignee Address: KR Seoul
- Agency: Goldilocks Zone IP Law
- Priority: KR10-2015-0042566 20150326
- Main IPC: C07K7/56
- IPC: C07K7/56 ; C07K14/47 ; G01N33/68 ; G01N33/564 ; G01N33/577
Abstract:
Rheumatoid arthritis is efficiently diagnosed with improved patient's convenience using a rheumatoid arthritis diagnosis composition and a kit, each including cyclic citrullinated peptide (CCP), a rheumatoid arthritis diagnosis method using the CCP, the rheumatoid arthritis diagnosis composition, or the kit, a method of obtaining information for rheumatoid arthritis diagnosis, and a method of screening a novel diagnostic marker for rheumatoid arthritis.
Public/Granted literature
Information query
